- This event has passed.
BVS’ Innovation Symposium & Vendor Expo, Cambridge
April 27 @ 4:00 pm - 8:00 pm
We are very excited to announce our indoor Innovation Symposium & Vendor Expo at the Le Méridien Boston Cambridge, 20 Sidney Street, Cambridge, MA 02139
This biotech community event will bring together researchers from local biotech/pharma accounts in Cambridge/Boston and the surrounding areas to see the latest in tools, technologies and equipment to help advance life science research.
This event will feature numerous technical presentations, vendor exhibits and will be highlighted by the keynote address.
For this annual gala, we are happy to announce that the keynote address will be given by Dr. Linda Malkas, PhD.
Dr. Malkas is a Professor of Molecular Diagnostics and Experimental Therapeutics at City of Hope and serves as the Dean for Translational Science, External Affairs. She is a world-renowned expert in the areas of DNA replication and repair, as well as cancer cell biomarker and therapeutic target discovery. She has had a stellar scientific career, advancing research in women’s health with a particular focus on breast cancer as well as in the children’s cancer neuroblastoma. She is best known for her discovery of a molecule that can inhibit certain activities in cancerous cells. In 2017, Malkas was named to the board of CIRM, California’s revolutionary stem cell research center. She also serves on the External Advisory Boards of several major National Cancer Institute-designated Cancer Centers throughout the US. In addition, she chairs the Oncology Study Section of the Veterans Administration, serves on the Department of Defense Ovarian Cancer Integration Panel, and has chaired several National Cancer Institute study sections. She came to City of Hope specifically for its reputation as a bench-to-bedside facility – a place where laboratory discoveries quickly make their way to patients. Her new drug AOH1996 that specifically targets the form of the PCNA molecule in cancer cells entered first in human phase one clinical trial at City of Hope in September 2022.
4:00pm – 5:00pm: Vendor Expo, Networking, Appetizers and Drinks
5:00pm – 5:20pm: Keynote Speaker : “How a Meeting with a Photographer Led to the Creation of AOH1996″ – Dr. Linda Malkas, PhD, Dean for Translational Science, External Affairs, City of Hope
Dr. Malkas is a Professor of Molecular Diagnostics and Experimental Therapeutics at City of Hope and serves as the Dean for Translational Science, External Affairs. She is a world-renowned expert in the areas of DNA replication and repair, as well as cancer cell biomarker and therapeutic target discovery. Her new drug AOH1996 that specifically targets the form of the PCNA molecule in cancer cells entered first in human phase one clinical trial at City of Hope in September 2022. For additional information on Dr. Malkas and her accomplishments, go to: https://www.cityofhope.org/linda-malkas
5:20pm – 5:40pm: Vendor Technical Talk: “Biology at True Resolution: Integrated Single Cell, Spatial and In Situ Analysis of FFPE with 10X Genomics” presented by Caroline Petersen, Science and Technology Advisor, 10x Genomics
5:40pm – 6:00pm: Vendor Technical Talk: “Critical new tools to understand mechanisms and modes of action from single molecule and molecular complex dynamics to cellular avidity” presented by Brendan Brinkman, Pharma/Biotech Market Development Strategist for the Dynamic Single Molecule Unit, LUMICKS and Dr. Sliwa, Sr. Account Manager in the Immuno-Oncology Unit, LUMICKS
6:00pm – 6:20pm: Vendor Technical Talk: “Understanding Biomolecular Behavior with Mass Photometry” presented by Gael Nicolas, Senior Technical Sales Specialist, Refeyn Inc
6:20pm – 6:40pm: Vendor Technical Talk: “Multimode Detection with the Envision Nexus showcasing Luminescence, HTRF and Alpha Detection” presented by Jordan Attwood, Principal Sales Specialist in New England, PerkinElmer Life Sciences
6:40pm – 8:00pm: Vendor Expo, Networking, Appetizers and Drinks
We are looking forward to seeing everyone.
- April 27
4:00 pm - 8:00 pm